BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12528767)

  • 1. Regulation and targets of receptor tyrosine kinases.
    Pawson T
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S3-10. PubMed ID: 12528767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Phosphorylation of SRC Homology 3 Domains by Tyrosine Kinase Receptors Disassembles Ligand-Induced Signaling Networks.
    Dionne U; Chartier FJM; López de Los Santos Y; Lavoie N; Bernard DN; Banerjee SL; Otis F; Jacquet K; Tremblay MG; Jain M; Bourassa S; Gish GD; Gagné JP; Poirier GG; Laprise P; Voyer N; Landry CR; Doucet N; Bisson N
    Mol Cell; 2018 Jun; 70(6):995-1007.e11. PubMed ID: 29910111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling.
    Wagner MJ; Stacey MM; Liu BA; Pawson T
    Cold Spring Harb Perspect Biol; 2013 Dec; 5(12):a008987. PubMed ID: 24296166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions.
    Hock B; Böhme B; Karn T; Feller S; Rübsamen-Waigmann H; Strebhardt K
    Oncogene; 1998 Jul; 17(2):255-60. PubMed ID: 9674711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH2 and PTB domain interactions in tyrosine kinase signal transduction.
    Shoelson SE
    Curr Opin Chem Biol; 1997 Aug; 1(2):227-34. PubMed ID: 9667855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The signal transduction of receptor tyrosine kinase].
    Takada T; Matozaki T; Kasuga M
    Nihon Rinsho; 1998 Jul; 56(7):1756-62. PubMed ID: 9702050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SH2 and PTB domains in tyrosine kinase signaling.
    Schlessinger J; Lemmon MA
    Sci STKE; 2003 Jul; 2003(191):RE12. PubMed ID: 12865499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.
    Ellis C; Kasmi F; Ganju P; Walls E; Panayotou G; Reith AD
    Oncogene; 1996 Apr; 12(8):1727-36. PubMed ID: 8622893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
    van der Geer P; Wiley S; Pawson T
    Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases.
    Brdicka T; Kadlecek TA; Roose JP; Pastuszak AW; Weiss A
    Mol Cell Biol; 2005 Jun; 25(12):4924-33. PubMed ID: 15923611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region.
    Zisch AH; Kalo MS; Chong LD; Pasquale EB
    Oncogene; 1998 May; 16(20):2657-70. PubMed ID: 9632142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoinhibitory mechanisms in receptor tyrosine kinases.
    Hubbard SR
    Front Biosci; 2002 Feb; 7():d330-40. PubMed ID: 11815286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine kinase signalling pathways.
    Pawson T
    Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins.
    Koch CA; Anderson D; Moran MF; Ellis C; Pawson T
    Science; 1991 May; 252(5006):668-74. PubMed ID: 1708916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent.
    Castagnino P; Biesova Z; Wong WT; Fazioli F; Gill GN; Di Fiore PP
    Oncogene; 1995 Feb; 10(4):723-9. PubMed ID: 7532293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3).
    Davis TL; Walker JR; Loppnau P; Butler-Cole C; Allali-Hassani A; Dhe-Paganon S
    Structure; 2008 Jun; 16(6):873-84. PubMed ID: 18547520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The insulin receptor: both a prototypical and atypical receptor tyrosine kinase.
    Hubbard SR
    Cold Spring Harb Perspect Biol; 2013 Mar; 5(3):a008946. PubMed ID: 23457259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected.
    Koytiger G; Kaushansky A; Gordus A; Rush J; Sorger PK; MacBeath G
    Mol Cell Proteomics; 2013 May; 12(5):1204-13. PubMed ID: 23358503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the Src family tyrosine kinase Fyn with TrkB.
    Iwasaki Y; Gay B; Wada K; Koizumi S
    J Neurochem; 1998 Jul; 71(1):106-11. PubMed ID: 9648856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.